Top

Published in:

Open Access 01-10-2012 | Review

Recognition and diagnosis of sleep disorders in Parkinson’s disease

Authors: Maartje Louter, Willemijn C. C. A. Aarden, Joy Lion, Bastiaan R. Bloem, Sebastiaan Overeem

Published in: Journal of Neurology | Issue 10/2012

Abstract

Sleep disturbances are among the most frequent and incapacitating non-motor symptoms of Parkinson’s disease (PD), and are increasingly recognized as an important determinant of impaired quality of life. Here we review several recent developments regarding the recognition and diagnosis of sleep disorders in PD. In addition, we provide a practical and easily applicable approach to the diagnostic process as a basis for tailored therapeutic interventions. This includes a stepwise scheme that guides the clinical interview and subsequent ancillary investigations. In this scheme, the various possible sleep disorders are arranged not in order of prevalence, but in a ‘differential diagnostic’ order. We also provide recommendations for the use of sleep registrations such as polysomnography. Furthermore, we point out when a sleep specialist could be consulted to provide additional diagnostic and therapeutic input. This structured approach facilitates early detection of sleep disturbances in PD, so treatment can be initiated promptly.

Adler CH, Caviness JN, Hentz JG, Lind M, Tiede J (2003) Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson’s disease. Mov Disord 18:287–293PubMedCrossRef

Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119PubMedCrossRef

Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson’s disease and sleepiness: an integral part of PD. Neurology 58:1019–1024PubMedCrossRef

Barone P, Amboni M, Vitale C, Bonavita V (2004) Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson’s disease. Neurology 63:S35–S38PubMedCrossRef

Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL (2005) Parkinsonism with excessive daytime sleepiness—a narcolepsy-like disorder? J Neurol 252:139–145PubMedCrossRef

Boeve BF, Silber MH, Ferman TJ (2003) Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 4:281–284

Bossenbroek L, Kosse N, Ten Hacken N, Gordijn M, Van der Hoeven J, De Greef M (2010) Validation of the DynaPort MiniMod during sleep: a pilot study. Percept Mot Skills 111:936–946PubMedCrossRef

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213PubMedCrossRef

Carrier J, Frenette S, Montplaisir J, Paquet J, Drapeau C, Morettini J (2005) Effects of periodic leg movements during sleep in middle-aged subjects without sleep complaints. Mov Disord 20:1127–1132PubMedCrossRef

10.

Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Hogl B, Trenkwalder C (2002) The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 73:629–635PubMedCrossRef

11.

Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A, Odin P, Macphee G, Stocchi F, Ondo W, Sethi K, Schapira AH, Martinez Castrillo JC, Martinez-Martin P (2010) The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25:697–701CrossRef

12.

Chrisp P, Mammen GJ (1991) Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson’s disease. Drugs Aging 1:228–248PubMedCrossRef

13.

Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494–499PubMedCrossRef

14.

Cochen De Cock V, Abouda M, Leu S, Oudiette D, Roze E, Vidailhet M, Similowski T, Arnulf I (2010) Is obstructive sleep apnea a problem in Parkinson’s disease? Sleep Med 11:247–252PubMedCrossRef

15.

Comella CL, Nardine TM, Diederich NJ, Stebbins GT (1998) Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology 51:526–529PubMedCrossRef

16.

De Cock VC, Vidailhet M, Leu S, Texeira A, Apartis E, Elbaz A, Roze E, Willer JC, Derenne JP, Agid Y, Arnulf I (2007) Restoration of normal motor control in Parkinson’s disease during REM sleep. Brain 130:450–456PubMedCrossRef

17.

Eisensehr I, van Lindeiner H, Jager M, Noachtar S (2001) REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson’s disease: is there a need for polysomnography? J Neurol Sci 186:7–11PubMedCrossRef

18.

Fabbrini G, Barbanti P, Aurilia C, Vanacore N, Pauletti C, Meco G (2002) Excessive daytime sleepiness in de novo and treated Parkinson’s disease. Mov Disord 17:1026–1030PubMedCrossRef

19.

Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ (1990) Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 5:280–285PubMedCrossRef

20.

Frauscher B, Iranzo A, Hogl B, Casanova-Molla J, Salamero M, Gschliesser V, Tolosa E, Poewe W, Santamaria J (2008) Quantification of electromyographic activity during REM sleep in multiple muscles in REM sleep behavior disorder. Sleep 31:724–731PubMed

21.

Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou J-S, Marsh L, Nail L, Shulman L, Taylor CB (2007) Fatigue in Parkinson’s disease: a review. Mov Disord 22:297–308PubMedCrossRef

22.

Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, van Duinen SG, Lammers GJ, Swaab DF (2007) Hypocretin (orexin) loss in Parkinson’s disease. Brain 130:1577–1585PubMedCrossRef

23.

Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S (1999) Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52:1908–1910PubMedCrossRef

24.

Gagnon JF, Bedard MA, Fantini ML, Petit D, Panisset M, Rompre S, Carrier J, Montplaisir J (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 59:585–589PubMedCrossRef

25.

Garcia-Borreguero D, Larrosa O, Bravo M (2003) Parkinson’s disease and sleep. Sleep med rev 7:115–129

26.

Ghorayeb I, Yekhlef F, Bioulac B, Tison F (2005) Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance. Sleep Med 6:359–362

27.

Ghorayeb I, Loundou A, Auquier P, Dauvilliers Y, Bioulac B, Tison F (2007) A nationwide survey of excessive daytime sleepiness in Parkinson’s disease in France. Mov Disord 22:1567–1572PubMedCrossRef

28.

Gjerstad MD, Boeve B, Wentzel-Larsen T, Aarsland D, Larsen JP (2008) Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time. J Neurol Neurosurg Psychiatry 79:387–391PubMedCrossRef

29.

Happe S, Berger K, Investigators FS (2001) The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson’s disease—a prospective study. J Neurol 248:1062–1067PubMedCrossRef

30.

Hobson DE, Lang AE, Martin WRW, Razmy A, Rivest J, Fleming J (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian movement disorders group. JAMA 287:455–463PubMedCrossRef

31.

Hogl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG (2010) Scales to assess sleep impairment in Parkinson’s disease: critique and recommendations. Mov Disord 25:2704–2716PubMedCrossRef

32.

Iranzo A, Frauscher B, Santos H, Gschliesser V, Ratti L, Falkenstetter T, Sturner C, Salamero M, Tolosa E, Poewe W, Santamaria J, Hogl B (2011) Usefulness of the SINBAR electromyographic montage to detect the motor and vocal manifestations occurring in REM sleep behavior disorder. Sleep Med 12:284–288PubMedCrossRef

33.

Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, Tolosa E (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572–577PubMedCrossRef

34.

Iranzo A, Santamaria J (2005) Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep 28:203–206PubMed

35.

Iranzo A, Santamaria J, Tolosa E (2000) Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet 356:1329–1330

36.

Iranzo A, Santamaria J, Tolosa E, et al (2004) Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 63:930–932

37.

Jansen EN, Meerwaldt JD (1988) Madopar HBS in Parkinson patients with nocturnal akinesia. Clin neurol neurosurgery 90:35–39

38.

Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545PubMed

39.

Korner Y, Meindorfner C, Moller JC, Stiasny-Kolster K, Haja D, Cassel W, Oertel WH, Kruger HP (2004) Predictors of sudden onset of sleep in Parkinson’s disease. Mov Disord 19:1298–1305PubMedCrossRef

40.

Kwon DY, Seo WK, Yoon HK, Park MH, Koh SB, Park KW (2010) Transcranial brain sonography in Parkinson’s disease with restless legs syndrome. Mov Disord 25:1373–1378PubMedCrossRef

41.

Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 11:512–519PubMedCrossRef

42.

Magalhaes M, Wenning GK, Daniel SE, Quinn NP (1995) Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson’s disease—a retrospective comparison. Acta Neurol Scand 91:98–102PubMedCrossRef

43.

Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM (2003) Assessment of sleep and sleepiness in Parkinson disease. Sleep 26:1049–1054PubMed

44.

Menza M, Dobkin RD, Marin H, Bienfait K (2010) Sleep disturbances in Parkinson’s disease. Mov Disord 25(Suppl 1):S117–S122PubMedCrossRef

45.

Montplaisir J, Gagnon JF, Fantini ML, Postuma RB, Dauvilliers Y, Desautels A, Rompre S, Paquet J (2010) Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 25:2044–2051PubMedCrossRef

46.

Nausieda PA, Weiner WJ, Kaplan LR, Weber S, Klawans HL (1982) Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 5:183–194PubMedCrossRef

47.

Obeso JA, Grandas F, Vaamonde J, Luquin MR, Artieda J, Lera G, Rodriguez ME, Martinez-Lage JM (1989) Motor complications associated with chronic levodopa therapy in Parkinson’s disease. Neurology 39:11–19PubMed

48.

Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J (2001) Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 57:1392–1396PubMedCrossRef

49.

Ondo WG, Vuong KD, Jankovic J (2002) Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59:421–424PubMedCrossRef

50.

Overeem S, van Hilten JJ, Ripley B, Mignot E, Nishino S, Lammers GJ (2002) Normal hypocretin-1 levels in Parkinson’s disease patients with excessive daytime sleepiness. Neurology 58:498–499PubMedCrossRef

51.

Paus S, Brecht HM, Koster J, Seeger G, Klockgether T, Wullner U (2003) Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 18:659–667PubMedCrossRef

52.

Poryazova R, Benninger D, Waldvogel D, Bassetti CL (2010) Excessive daytime sleepiness in Parkinson’s disease: characteristics and determinants. Eur Neurol 63:129–135PubMedCrossRef

53.

Puca FM, Bricolo A, Turella G (1973) Effect of l-dopa or amantadine therapy on sleep spindles in Parkinsonism. Electroencephalogr Clin Neurophysiol 35:327–330PubMedCrossRef

54.

Qin Z, Zhang L, Sun F, Fang X, Meng C, Tanner C, Chan P (2009) Health related quality of life in early Parkinson’s disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 15:767–771PubMedCrossRef

55.

Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1434PubMedCrossRef

56.

Reuter I, Ellis CM, Ray Chaudhuri K (1999) Nocturnal subcutaneous apomorphine infusion in Parkinson’s disease and restless legs syndrome. Acta neurologica Scandinavica 100:163–167

57.

Ryu JH, Lee MS, Baik JS (2011) Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson’s disease. Parkinsonism Relat Disord 17:201–203PubMedCrossRef

58.

Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F (2003) Health-related quality of life and sleep disorders in Parkinson’s disease. Neurol Sci 24:209–210PubMedCrossRef

59.

Schenck C, Mahowald M (1990) Polysomnographic, neurologic, psychiatric, and clinical outcome report of 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Clev Clin J Med 57:10–24

60.

Scofield H, Roth T, Drake C (2008) Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. Sleep 31:1221–1227PubMed

61.

Silber MH, Levine S (2000) Stridor and death in multiple system atrophy. Mov Disord 15:699–704

62.

Sixel-Doring F, Schweitzer M, Mollenhauer B, Trenkwalder C (2011) Intraindividual variability of REM sleep behavior disorder in Parkinson’s disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine. J Clin Sleep Med 7:75–80PubMed

63.

Tandberg E, Larsen JP, Karlsen K (1998) A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 13:895–899PubMedCrossRef

64.

Tandberg E, Larsen JP, Karlsen K (1999) Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord 14:922–927PubMedCrossRef

65.

Thannickal TC, Lai YY, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson’s disease. Brain 130:1586–1595PubMedCrossRef

66.

Trenkwalder C, Kohnen R, Hogl B, Metta V, Sixel-Doring F, Frauscher B, Hulsmann J, Martinez-Martin P, Chaudhuri KR (2011) Parkinson’s disease sleep scale-validation of the revised version PDSS-2. Mov Disord 26:644–652PubMedCrossRef

67.

Trenkwalder C, Kies B, Rudzinska M, et al (2011) Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26:90–99

68.

Trotti LM, Bliwise DL (2010) No increased risk of obstructive sleep apnea in Parkinson’s disease. Mov Disord 25:2246–2249PubMedCrossRef

69.

Valko PO, Waldvogel D, Weller M, Bassetti CL, Held U, Baumann CR (2010) Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 17:1428–1436PubMedCrossRef

70.

Verbaan D, van Rooden SM, van Hilten JJ, Rijsman RM (2010) Prevalence and clinical profile of restless legs syndrome in Parkinson’s disease. Mov Disord 25:2142–2147PubMedCrossRef

71.

Wetter TC, Collado-Seidel V, Pollmacher T, Yassouridis A, Trenkwalder C (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 23:361–367PubMed

72.

Yamaguchi M, Arai K, Asahina M, Hattori T (2003) Laryngeal stridor in multiple system atrophy. Eur Neurol 49:154–159PubMedCrossRef

73.

Yasui K, Inoue Y, Kanbayashi T, Nomura T, Kusumi M, Nakashima K (2006) CSF orexin levels of Parkinson’s disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 250:120–123PubMedCrossRef

Title: Recognition and diagnosis of sleep disorders in Parkinson’s disease
Authors: Maartje Louter
Willemijn C. C. A. Aarden
Joy Lion
Bastiaan R. Bloem
Sebastiaan Overeem
Publication date: 01-10-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 10/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-012-6505-7

ACC 2024 Congress

Springer Medicine

Recognition and diagnosis of sleep disorders in Parkinson’s disease

Abstract

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2012

SPECT-DTPA as a tool for evaluating the blood–brain barrier in post-stroke seizures

Management of status epilepticus

Adolf von Strümpell: a key yet neglected protagonist of neurology

Fear of heights in ancient China

Neurological disorder screening in the elderly in low-income countries

Intracerebral mass lesion diagnosed as cryptococcoma in a patient with sarcoidosis, a rare opportunistic manifestation induced by immunosuppression with corticosteroids